Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide

Clinical trial NCT03580668 · COMPLETED

Trial details

NCT number: NCT03580668
Sponsor: Gilead Sciences
Status: COMPLETED
Study type: OBSERVATIONAL

HIV-1-infection

Start date: 2018-11-13
Primary completion: 2024-06-03
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.